Amerinet, a national healthcare group purchasing organization, has announced it has signed an agreement with JCB Laboratories, a provider of sterile pharmaceuticals, for custom-formulated materials.
These materials, according to an Amerinet news release, include sterile and preservative-free compounds, discontinued or back-ordered products and unique sizes and concentrations.
The agreement went into effect May 1 and goes through April 30, 2014.
Read the news release about the JCB Labs agreement with Amerinet.
View all new Amerinet agreements.
More Articles Featuring Amerinet:
Amerinet Names Canonsburg General Hospital Recipient of Healthcare Achievement Award
Amerinet Announces Toolkit and Educational Resources on Healthcare Associated Infections
Amerinet Receives Award for Contributions to Environmentally Responsible Healthcare